Gregory Russotti
CIK: 0001867305
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Century Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 14, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct2.6K shares at avg. $1.93$5K - Sep 8, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct534 shares at avg. $2.05$1K - Jun 12, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct2.6K shares at avg. $2.23$6K - Jun 8, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct524 shares at avg. $2.11$1K - Mar 12, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct10.1K shares at avg. $2.55$26K - Mar 9, 2026IPSC
Century Therapeutics, Inc.
Sale(S)Direct479 shares at avg. $2.54$1K - Feb 2, 2026IPSC
Century Therapeutics, Inc.
Award(A)Direct135K shares- - Dec 8, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct526 shares at avg. $0.53$279.832 - Sep 8, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct539 shares at avg. $0.50$269.5 - Jun 9, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct526 shares at avg. $0.62$327.172 - Mar 11, 2025IPSC
Century Therapeutics, Inc.
Award(A)Direct120K shares- - Mar 10, 2025IPSC
Century Therapeutics, Inc.
Sale(S)Direct2.4K shares at avg. $0.61$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 2,587 | $1.93 | $4,993 | Direct |
| Sep 8, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 534 | $2.05 | $1,095 | Direct |
| Jun 12, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 2,584 | $2.23 | $5,767 | Direct |
| Jun 8, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 524 | $2.11 | $1,106 | Direct |
| Mar 12, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 10,076 | $2.55 | $25,684 | Direct |
| Mar 9, 2026 | IPSC Century Therapeutics, Inc. | Sale(S) | 479 | $2.54 | $1,215 | Direct |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc. | Award(A) | 135,000 | - | $0 | Direct |
| Dec 8, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 526 | $0.53 | $280 | Direct |
| Sep 8, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 539 | $0.50 | $270 | Direct |
| Jun 9, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 526 | $0.62 | $327 | Direct |
| Mar 11, 2025 | IPSC Century Therapeutics, Inc. | Award(A) | 120,000 | - | - | Direct |
| Mar 10, 2025 | IPSC Century Therapeutics, Inc. | Sale(S) | 2,360 | $0.61 | $1,451 | Direct |
1-12 of 12 transactions
About Russotti Gregory
Russotti Gregory (SEC CIK 0001867305) files insider reports with the SEC as Officer of Century Therapeutics, Inc. (IPSC).
Signal8 holds 11 ownership filings by Russotti Gregory, all Form 4s, filed between Mar 12, 2025 and Sep 15, 2026. Those filings report 12 transactions, from Mar 10, 2025 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Russotti Gregory's filings is in PHILADELPHIA, PA.
Recent filings by Russotti Gregory
- Sep 14, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Sep 8, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Jun 12, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Jun 8, 2026: Open-market sale of IPSC shares (Form 4, code S).
- Mar 12, 2026: Open-market sale of IPSC shares (Form 4, code S).
Other insiders filing for Century Therapeutics, Inc. (IPSC)
- Carr Douglas, SVP Finance & Operations
- Pfeiffenberger Brent, President and CEO
- Truitt Joseph, Director
- Cowan Chad, Chief Scientific Officer
- Riva Alessandro, Director
- Quimi Daphne, Director